Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Real-time Estimate Cboe BZX
Other stock markets
 11:38:35 2024-04-29 am EDT 		5-day change 1st Jan Change
4.765 USD +3.14% Intraday chart for Vanda Pharmaceuticals Inc. -0.83% +12.80%
Apr. 25 Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer RE
Apr. 22 Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors
CI
Insider Sell: Vanda Pharmaceuticals
MT
H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc
CI
Insider Sell: Vanda Pharmaceuticals
MT
Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer
CI
Insider Sell: Vanda Pharmaceuticals
MT
Insider Sell: Vanda Pharmaceuticals
MT
Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares
MT
Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director
CI
Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020
CI
Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020
CI
Vanda Pharmaceuticals Inc. Announces Board Changes
CI
Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020
CI
Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer
CI
Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors
CI
Vanda Pharmaceuticals Announces Management Appointments
CI
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors
CI
Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary
CI
Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors
CI
Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.
  5. Insiders